This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lobbezoo, F. Articles by Lavigne, G.J. Search for Related Content PubMed PubMed Citation Articles by Lobbezoo, F. Articles by Lavigne, G.J. Social Bookmarking                         What's this?

Effects of the D2 Receptor Agonist Bromocriptine on Sleep Bruxism: Report of Two Single-patient Clinical Trials

Faculté de Medecine Dentaire, Universite de Montreal, C.P. 6128, Succ. Centre-Ville, Montreal, Quebec, Canada H3C 3J7, Centre de Recherche en Sciences Neurologiques, Departement de Physiologie, Faculte de Medecine, Universite de Montreal, Centre d'Etude du Sommeil, Departement de Psychiatrie, Hopital du Sacre-Coeur

J.-P. Soucy

Département de Medecine Nucleaire, Hopital Notre-Dame, Montreal, Quebec, Canada

N.G. Hartman

Département de Medecine Nucleaire, Hopital Notre-Dame, Montreal, Quebec, Canada

J.Y. Montplaisir

Centre de Recherche en Sciences Neurologiques, Departement de Physiologie, Faculte de Medecine, Universite de Montreal, Centre d'Etude du Sommeil, Departement de Psychiatrie, Hopital du Sacre-Coeur

G.J. Lavigne

Faculté de Medecine Dentaire, Universite de Montreal, C.P. 6128, Succ. Centre-Ville, Montreal, Quebec, Canada H3C 3J7, Centre de Recherche en Sciences Neurologiques, Departement de Physiologie, Faculte de Medecine, Universite de Montreal, Centre d'Etude du Sommeil, Departement de Psychiatrie, Hopital du Sacre-Coeur

An altered dopamine receptor status has been associated with sleep bruxism. Evidence from a functional neuro-imaging study has implicated an abnormal side imbalance in striatal D2 receptor expression in its pathophysiology. To assess the significance of this finding, we studied the effects of short-term administration of the preferential dopamine D2 receptor agonist bromocriptine on sleep bruxism in a double-blind, placebo-controlled polysomnographic and neuro-imaging study with a single crossover design. Six otherwise healthy and drug-free patients with sleep bruxism were entered into the trial. One of the patients dropped out due to an intercurrent illness, while three others were discontinued from the study due to severe adverse reactions to bromocriptine. Because of the high frequency and intensity of the side-effects, the trial was interrupted. Two patients, however, completed the trial without any adverse reactions. Their outcome measures are presented as single-patient clinical trials. Following a two-week administration of bromocriptine, both patients showed a decrease in the number of bruxism episodes per hour of sleep of about 20% to 30% with respect to the placebo. While no significant differences between both conditions (i.e., placebo and bromocriptine) were found for the number of bruxism bursts per episode, significantly lower root-mean-squared EMG levels per bruxism burst occurred during bromocriptine use. In association with this polysomnographically established attenuation of sleep bruxism, bromocriptine afforded a decreased abnormal side distribution of striatal D2 receptor binding, as was evidenced by single-photon-emission computed tomography using the radioactive D2 receptor antagonist iodine-123-iodobenzamide. This study supports previous suggestions that the central dopaminergic system may be involved in the modulation of sleep bruxism.

To see if the present findings apply across a population, investigators should use a peripheral D-2 antagonist to prevent side-effects.

Key Words: sleep bruxism • bromocriptine • dopamine D2 receptors • iodine-123-iodobenzamide ([123I]IBZM) • single-photon-emission computed tomography (SPECT).

Journal of Dental Research, Vol. 76, No. 9, 1610-1614 (1997)
DOI: 10.1177/00220345970760091401


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G.J. Lavigne, T. Kato, A. Kolta, and B.J. Sessle NEUROBIOLOGICAL MECHANISMS INVOLVED IN SLEEP BRUXISM Critical Reviews in Oral Biology & Medicine, January 1, 2003; 14(1): 30 - 46. [Abstract] [Full Text] [PDF]

				E.-K. TAN and J. JANKOVIC TREATING SEVERE BRUXISM WITH BOTULINUM TOXIN J Am Dent Assoc, February 1, 2000; 131(2): 211 - 216. [Abstract] [Full Text] [PDF]

				M.P. Areso, M.T. Giralt, B. Sainz, M. Prieto, P. Garcia-Vallejo, and F.M. Gomez Occlusal Disharmonies Modulate Central Catecholaminergic Activity in the Rat Journal of Dental Research, June 1, 1999; 78(6): 1204 - 1213. [Abstract] [PDF]